| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $900K | — | +19.5% |
| R&D Expense | $33.4M | — | +55.5% |
| SG&A Expense | $10.5M | — | +86.6% |
| Operating Income | -$47.9M | — | -80.0% |
| Pre-tax Income | -$47.4M | — | -75.0% |
| Income Tax | $200K | — | — |
| Net Income | -$47.6M | — | -75.8% |
| EPS (Basic) | -$0.11 | — | +57.7% |
| EPS (Diluted) | -$0.11 | — | +57.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $229.2M | +18.0% | +1668.2% |
| Current Assets | $246.7M | +15.9% | +746.4% |
| Total Assets | $266.4M | +14.0% | +426.9% |
| Current Liabilities | $51.8M | -10.7% | +28.3% |
| Total Liabilities | $58.4M | -10.1% | +22.5% |
| Stockholders' Equity | $207.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$49.1M | — | -149.6% |
| Capital Expenditures | $400K | — | +3900.0% |
| Investing Cash Flow | -$300K | — | +20.0% |
| Financing Cash Flow | $88.9M | — | — |
| Free Cash Flow | -$49.5M | — | -151.5% |
| +7136.3% |